← Evidence map

ArticleCell death discovery2021

Correction to: Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML.

Wittawat Chantkran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34230455